PortfoliosLab logoPortfoliosLab logo
ABEO vs. BLZE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABEO vs. BLZE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abeona Therapeutics Inc. (ABEO) and Backblaze, Inc. (BLZE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABEO achieves a 32.45% return, which is significantly lower than BLZE's 277.68% return.


ABEO

1D
-1.97%
1M
26.22%
6M
34.49%
YTD
32.45%
1Y
21.60%
3Y*
19.41%
5Y*
-28.93%
10Y*
-19.49%

BLZE

1D
-1.29%
1M
122.22%
6M
252.00%
YTD
277.68%
1Y
241.09%
3Y*
48.36%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABEO vs. BLZE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ABEO
Abeona Therapeutics Inc.
32.45%-5.39%11.18%62.66%-63.44%-64.05%
BLZE
Backblaze, Inc.
277.68%-22.59%-20.69%23.41%-63.59%-11.11%

Correlation

The correlation between ABEO and BLZE is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2021

0.20

Fundamentals

Market Cap

ABEO:

$397.83M

BLZE:

$1.06B

EPS

ABEO:

$1.12

BLZE:

-$0.39

PS Ratio

ABEO:

28.32

BLZE:

6.75

PB Ratio

ABEO:

2.73

BLZE:

12.33

Total Revenue (TTM)

ABEO:

$14.54M

BLZE:

$149.89M

Gross Profit (TTM)

ABEO:

$7.56M

BLZE:

$93.07M

EBITDA (TTM)

ABEO:

-$98.70M

BLZE:

-$899.00K

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Abeona Therapeutics Inc.

Backblaze, Inc.

Return for Risk

ABEO vs. BLZE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABEO
ABEO Risk / Return Rank: 5757
Overall Rank
ABEO Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
ABEO Sortino Ratio Rank: 5858
Sortino Ratio Rank
ABEO Omega Ratio Rank: 5555
Omega Ratio Rank
ABEO Calmar Ratio Rank: 5757
Calmar Ratio Rank
ABEO Martin Ratio Rank: 5454
Martin Ratio Rank

BLZE
BLZE Risk / Return Rank: 9090
Overall Rank
BLZE Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
BLZE Sortino Ratio Rank: 9494
Sortino Ratio Rank
BLZE Omega Ratio Rank: 9595
Omega Ratio Rank
BLZE Calmar Ratio Rank: 8888
Calmar Ratio Rank
BLZE Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABEO vs. BLZE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abeona Therapeutics Inc. (ABEO) and Backblaze, Inc. (BLZE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABEOBLZEDifference
Sharpe ratioReturn per unit of total volatility

-1.85

Sortino ratioReturn per unit of downside risk

-2.46

Omega ratioGain probability vs. loss probability

1.11

1.51

-0.40

Calmar ratioReturn relative to maximum drawdown

0.46

3.33

-2.87

Martin ratioReturn relative to average drawdown

0.75

5.36

-4.60

ABEO vs. BLZE - Sharpe Ratio Comparison

The current ABEO Sharpe Ratio is 0.37, which is lower than the BLZE Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of ABEO and BLZE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABEO vs. BLZE - Drawdown Comparison

The maximum ABEO drawdown since its inception was -100.00%, which is greater than BLZE's maximum drawdown of -89.49%. Use the drawdown chart below to compare losses from any high point for ABEO and BLZE.


Loading charts...

Drawdown Indicators


ABEOBLZEDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-89.49%

-10.51%

Max Drawdown (1Y)

Largest decline over 1 year

-42.32%

-69.21%

+26.89%

Max Drawdown (3Y)

Largest decline over 3 years

-63.48%

-72.02%

+8.54%

Max Drawdown (5Y)

Largest decline over 5 years

-93.33%

Max Drawdown (10Y)

Largest decline over 10 years

-99.58%

Current Drawdown

Current decline from peak

-100.00%

-44.13%

-55.87%

Average Drawdown

Average peak-to-trough decline

-90.66%

-77.19%

-13.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.67%

42.95%

-17.28%

Volatility

ABEO vs. BLZE - Volatility Comparison

The current volatility for Abeona Therapeutics Inc. (ABEO) is 13.32%, while Backblaze, Inc. (BLZE) has a volatility of 37.79%. This indicates that ABEO experiences smaller price fluctuations and is considered to be less risky than BLZE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABEOBLZEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.32%

37.79%

-24.47%

Volatility (6M)

Calculated over the trailing 6-month period

32.16%

73.64%

-41.48%

Volatility (1Y)

Calculated over the trailing 1-year period

52.01%

103.74%

-51.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.73%

84.72%

-5.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

90.23%

84.72%

+5.51%

Dividends

ABEO vs. BLZE - Dividend Comparison

Neither ABEO nor BLZE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ABEO vs. BLZE - Financials Comparison

This section allows you to compare key financial metrics between Abeona Therapeutics Inc. and Backblaze, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
8.72M
38.67M
(ABEO) Total Revenue
(BLZE) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ABEO and BLZE have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BLZE has higher volatility (37.79%) compared to ABEO (13.32%). In terms of maximum drawdown, ABEO dropped -100.00% vs BLZE's -89.49%.

BLZE currently has the higher Sharpe Ratio (2.22 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABEO and BLZE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer